Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-4598

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma ; volume:13 ; number:1 ; day:20 ; month:8 ; year:2014 ; pages:1-15 ; date:12.2014
Molecular cancer ; 13, Heft 1 (20.8.2014), 1-15, 12.2014

Creator: Wong, Deborah JL

Contributor: Robert, Lidia
Atefi, Mohammad S.
Lassen, Amanda
Avarappatt, Geetha
Cerniglia, Michael
Avramis, Earl
Tsoi, Jennifer
Foulad, David
Graeber, Thomas G.
Comin-Anduix, Begonya
Samatar, Ahmed
Lo, Roger S.
Ribas, Antoni
SpringerLink (Online service)

DOI: 10.1186/1476-4598-13-194

URN: urn:nbn:de:1111-201609063777

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wong, Deborah JL
Robert, Lidia
Atefi, Mohammad S.
Lassen, Amanda
Avarappatt, Geetha
Cerniglia, Michael
Avramis, Earl
Tsoi, Jennifer
Foulad, David
Graeber, Thomas G.
Comin-Anduix, Begonya
Samatar, Ahmed
Lo, Roger S.
Ribas, Antoni
SpringerLink (Online service)

Other Objects (12)

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

Optimizing the treatment of BRAF mutant melanoma

Novel combination therapies for BRAF-mutant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

$Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma$

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Hochschulschrift

Cognitive phenotyping of wildtype and mutant mouse lines

Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report

Variations of BRAF mutant allele percentage in melanomas

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

Optimizing the treatment of BRAF mutant melanoma

Novel combination therapies for BRAF-mutant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

$Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma$

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Hochschulschrift

Cognitive phenotyping of wildtype and mutant mouse lines

Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report

Variations of BRAF mutant allele percentage in melanomas

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

Optimizing the treatment of BRAF mutant melanoma

Novel combination therapies for BRAF-mutant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

$Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma$

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Hochschulschrift

Cognitive phenotyping of wildtype and mutant mouse lines

Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report

Variations of BRAF mutant allele percentage in melanomas

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

Optimizing the treatment of BRAF mutant melanoma

Novel combination therapies for BRAF-mutant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Cognitive phenotyping of wildtype and mutant mouse lines

Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report

Variations of BRAF mutant allele percentage in melanomas

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

Optimizing the treatment of BRAF mutant melanoma

Novel combination therapies for BRAF-mutant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Cognitive phenotyping of wildtype and mutant mouse lines

Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report

Variations of BRAF mutant allele percentage in melanomas

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Circulating tumor DNA allows early treatment monitoring in BRAF- and NRAS-mutant malignant melanoma

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagy

Optimizing the treatment of BRAF mutant melanoma

Novel combination therapies for BRAF-mutant melanoma

Variation of mutant allele frequency in NRAS Q61 mutated melanomas

Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma

Cognitive phenotyping of wildtype and mutant mouse lines

Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report

Variations of BRAF mutant allele percentage in melanomas

Related objects

Reset password